Statistics for Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
Total visits
| views | |
|---|---|
| Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation | 67 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Calprotectin and the Magnitude of Antibodies to Infliximab.pdf(legacy) | 86 |
| Calprotectin and the Magnitude of Antibodies to Infliximab.pdf | 5 |
Top country views
| views | |
|---|---|
| United States | 28 |
| China | 22 |
| Australia | 3 |
| Portugal | 3 |
| Germany | 2 |
| France | 2 |
| Singapore | 2 |
| Spain | 1 |
| Ireland | 1 |
| Mongolia | 1 |
| Poland | 1 |